Clinical study of azithromycin

Yoshiro Sawae, Hiroyasu Misumi, Koji Takaki, Toshiyuki Ishimaru, Masaharu Motomura, Yukio Kumagai, Makoto Katsuno, Nobuyuki Shimono, Hiroshi Inoue, Ikuo Sumita, Takatoshi Inoue

研究成果: ジャーナルへの寄稿学術誌査読


A clinical study of azithromycin (AZM), a newly developed oral macrolide antibacterial agent, was performed with the following results. AZM at a dose of 250 or 500 mg was administered once a day for 3 days to 22 patients, including 1 case of pharyngolaryngitis, 4 of acute bronchitis and 17 of pneumonia. The clinical effect was evaluated as excellent in 5, good in 13, poor in 1 and undetermined in 3 cases. Adverse reactions thought to have a causal relationship to AZM included coughing, dyspnea and fever in 1 case and a rigidity of anterior chest in 1 case. However, these symptoms disappeared within 1 month after the administration of AZM. Abnormal laboratory values due to drug administration were observed in 3 cases: increased eosinophils in 2, elevated GOT, GPT, ALP, γ-GTP, CRP and ESR in 1.

ジャーナルJapanese Journal of Chemotherapy
出版ステータス出版済み - 1995

!!!All Science Journal Classification (ASJC) codes

  • 薬理学
  • 薬理学(医学)


「Clinical study of azithromycin」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。